Literature DB >> 29225308

Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system.

Satoshi Nakamura1,2,3, Shoji Imamichi3,4, Kazuyoshi Masumoto5, Masashi Ito3,6, Akihisa Wakita1,3, Hiroyuki Okamoto1,3, Shie Nishioka1,3, Kotaro Iijima1, Kazuma Kobayashi1,3, Yoshihisa Abe3,6, Hiroshi Igaki1,3, Kazuyoshi Kurita2, Teiji Nishio7, Mitsuko Masutani3,4,8, Jun Itami1,3.   

Abstract

This study aimed to evaluate the residual radioactivity in mice induced by neutron irradiation with an accelerator-based boron neutron capture therapy (BNCT) system using a solid Li target. The radionuclides and their activities were evaluated using a high-purity germanium (HP-Ge) detector. The saturated radioactivity of the irradiated mouse was estimated to assess the radiation protection needs for using the accelerator-based BNCT system. 24Na, 38Cl, 80mBr, 82Br, 56Mn, and 42K were identified, and their saturated radioactivities were (1.4 ± 0.1) × 102, (2.2 ± 0.1) × 101, (3.4 ± 0.4) × 102, 2.8 ± 0.1, 8.0 ± 0.1, and (3.8 ± 0.1) × 101 Bq/g/mA, respectively. The 24Na activation rate at a given neutron fluence was found to be consistent with the value reported from nuclear-reactor-based BNCT experiments. The induced activity of each nuclide can be estimated by entering the saturated activity of each nuclide, sample mass, irradiation time, and proton current into the derived activation equation in our accelerator-based BNCT system.

Entities:  

Keywords:  accelerator-based BNCT; boron neutron capture therapy (BNCT); induced radioactivity; radioactivation

Mesh:

Substances:

Year:  2017        PMID: 29225308      PMCID: PMC5790759          DOI: 10.2183/pjab.93.051

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  34 in total

1.  A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy.

Authors:  C L Lee; X L Zhou; R J Kudchadker; F Harmon; Y D Harker
Journal:  Med Phys       Date:  2000-01       Impact factor: 4.071

2.  Determination of radionuclides produced by neutrons in heavily exposed workers of the JCO criticality accident in Tokai-mura for estimating an individual's neutron fluence.

Authors:  Y Muramatsu; Y Noda; H Yonehara; N Ishigure; S Yoshida; M Yukawa; K Tagami; T Ban-Nai; S Uchida; T Hirama; M Akashi; Y Nakamura
Journal:  J Radiat Res       Date:  2001-09       Impact factor: 2.724

3.  Neutron capture therapy with boron in the treatment of glioblastoma multiforme.

Authors:  L E FARR; W H SWEET; J S ROBERTSON; C G FOSTER; H B LOCKSLEY; D L SUTHERLAND; M L MENDELSOHN; E E STICKLEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1954-02

4.  AB-BNCT beam shaping assembly based on 7Li(p,n)7Be reaction optimization.

Authors:  D M Minsky; A J Kreiner; A A Valda
Journal:  Appl Radiat Isot       Date:  2011-03-15       Impact factor: 1.513

Review 5.  Conversion coefficients for use in radiological protection against external radiation. Adopted by the ICRP and ICRU in September 1995.

Authors: 
Journal:  Ann ICRP       Date:  1996

6.  Modeling the detection efficiency of an HP-Ge detector for use in boron neutron capture therapy.

Authors:  Satoshi Nakamura; Akihisa Wakita; Masashi Ito; Hiroyuki Okamoto; Shie Nishioka; Kotaro Iijima; Kazuma Kobayashi; Teiji Nishio; Hiroshi Igaki; Jun Itami
Journal:  Appl Radiat Isot       Date:  2017-04-02       Impact factor: 1.513

7.  L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours.

Authors:  Tsubasa Watanabe; Hiroki Tanaka; Satoshi Fukutani; Minoru Suzuki; Masahiro Hiraoka; Koji Ono
Journal:  Cancer Lett       Date:  2015-10-08       Impact factor: 8.679

8.  A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy.

Authors:  Gen Futamura; Shinji Kawabata; Hiroyuki Siba; Toshihiko Kuroiwa; Minoru Suzuki; Natsuko Kondo; Koji Ono; Yoshinori Sakurai; Minoru Tanaka; Tomoki Todo; Shin-Ichi Miyatake
Journal:  Radiat Oncol       Date:  2014-11-04       Impact factor: 3.481

9.  The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Hiroki Tanaka; Keizo Tano; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Yosuke Nakagawa; Tsubasa Watanabe; Akira Maruhashi; Koji Ono
Journal:  Springerplus       Date:  2014-03-07

10.  Boron neutron capture therapy induces cell cycle arrest and cell apoptosis of glioma stem/progenitor cells in vitro.

Authors:  Ting Sun; Zizhu Zhang; Bin Li; Guilin Chen; Xueshun Xie; Yongxin Wei; Jie Wu; Youxin Zhou; Ziwei Du
Journal:  Radiat Oncol       Date:  2013-08-06       Impact factor: 3.481

View more
  3 in total

1.  Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy.

Authors:  Fumiko Nakagawa; Hidehisa Kawashima; Taiki Morita; Hiroyuki Nakamura
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

2.  Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients.

Authors:  Hiroshi Igaki; Naoya Murakami; Satoshi Nakamura; Naoya Yamazaki; Tairo Kashihara; Akira Takahashi; Kenjiro Namikawa; Mihiro Takemori; Hiroyuki Okamoto; Kotaro Iijima; Takahito Chiba; Hiroki Nakayama; Ayaka Takahashi; Tomoya Kaneda; Kana Takahashi; Koji Inaba; Kae Okuma; Yuko Nakayama; Kazuaki Shimada; Hitoshi Nakagama; Jun Itami
Journal:  Clin Transl Radiat Oncol       Date:  2022-02-18

3.  Characterization of the relationship between neutron production and thermal load on a target material in an accelerator-based boron neutron capture therapy system employing a solid-state Li target.

Authors:  Satoshi Nakamura; Hiroshi Igaki; Masashi Ito; Hiroyuki Okamoto; Shie Nishioka; Kotaro Iijima; Hiroki Nakayama; Mihiro Takemori; Shoji Imamichi; Tairo Kashihara; Kana Takahashi; Koji Inaba; Kae Okuma; Naoya Murakami; Yoshihisa Abe; Yuko Nakayama; Mitsuko Masutani; Teiji Nishio; Jun Itami
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.